Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Peptic Ulcer

  Free Subscription


Articles published in Digestion

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    June 2018
  1. AKAZAWA Y, Ueyama H, Yao T, Komori H, et al
    Usefulness of Demarcation of Differentiated-Type Early Gastric Cancers after Helicobacter pylori Eradication by Magnifying Endoscopy with Narrow-Band Imaging.
    Digestion. 2018;98:175-184.
    PubMed     Text format     Abstract available


  2. BOLTIN D, Schmilovitz-Weiss H, Gingold-Belfer R, Leibovitzh H, et al
    Temporal Trends in Helicobacter pylori Eradication Success in a Test-and-Treat Population.
    Digestion. 2018;98:169-174.
    PubMed     Text format     Abstract available


    May 2018
  3. YAMADA A, Kaise M, Inoshita N, Toba T, et al
    Characterization of Helicobacter pylori-Naive Early Gastric Cancers.
    Digestion. 2018;98:127-134.
    PubMed     Text format     Abstract available


    April 2018
  4. TSUTSUMI K, Kusano C, Suzuki S, Gotoda T, et al
    Diagnostic Accuracy of Latex Agglutination Turbidimetric Immunoassay in Screening Adolescents for Helicobacter pylori Infection in Japan.
    Digestion. 2018;98:75-80.
    PubMed     Text format     Abstract available


  5. WINKELSETT L, Malfertheiner P, Wex T, Kandulski A, et al
    Mucosal Two-Step Pathogenesis in Gastroesophageal Reflux Disease: Repeated Weakly Acidic Stimulation and Activation of Protease-Activated Receptor-2 on Mucosal Interleukin-8 Secretion.
    Digestion. 2018;98:19-25.
    PubMed     Text format     Abstract available


  6. KOTACHI T, Ito M, Boda T, Kiso M, et al
    Clinical Significance of Reddish Depressed Lesions Observed in the Gastric Mucosa after Helicobacter pylori Eradication.
    Digestion. 2018;98:48-55.
    PubMed     Text format     Abstract available


    March 2018
  7. YAMADA S, Tomatsuri N, Kawakami T, Nakatsugawa Y, et al
    Helicobacter pylori Eradication Therapy Ameliorates Latent Digestive Symptoms in Chronic Atrophic Gastritis.
    Digestion. 2018;97:333-339.
    PubMed     Text format     Abstract available


  8. KODAMA M, Okimoto T, Mizukami K, Abe H, et al
    Endoscopic and Immunohistochemical Characteristics of Gastric Cancer with versus without Helicobacter Pylori Eradication.
    Digestion. 2018;97:288-297.
    PubMed     Text format     Abstract available


    February 2018
  9. MATSUURA S, Sakata Y, Tsuruoka N, Miyahara K, et al
    Outcomes of Patients Undergoing Endoscopic Hemostasis for the Upper Gastrointestinal Bleeding Were Not Influenced by the Timing of Hospital Emergency Visits: A Situation Prevailing in Japan.
    Digestion. 2018;97:260-266.
    PubMed     Text format     Abstract available


  10. KOJIMA Y, Takeuchi T, Sanomura M, Higashino K, et al
    Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study.
    Digestion. 2018;97:70-75.
    PubMed     Text format     Abstract available


  11. MATSUMURA T, Arai M, Ishigami H, Fujie M, et al
    Evaluation of Esophageal Mucosal Integrity in Patients with Gastroesophageal Reflux Disease.
    Digestion. 2018;97:31-37.
    PubMed     Text format     Abstract available


    January 2018
  12. OZAKI H, Harada S, Takeuchi T, Kawaguchi S, et al
    Vonoprazan, a Novel Potassium-Competitive Acid Blocker, Should Be Used for the Helicobacter pylori Eradication Therapy as First Choice: A Large Sample Study of Vonoprazan in Real World Compared with Our Randomized Control Trial Using Second-Generation
    Digestion. 2018;97:212-218.
    PubMed     Text format     Abstract available


  13. SAHARA S, Sugimoto M, Ichikawa H, Kagami T, et al
    Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial.
    Digestion. 2018;97:163-169.
    PubMed     Text format     Abstract available


  14. SHIOTANI A, Katsumata R, Gouda K, Fukushima S, et al
    Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
    Digestion. 2018;97:154-162.
    PubMed     Text format     Abstract available


  15. NAITO Y, Kashiwagi K, Takagi T, Andoh A, et al
    Intestinal Dysbiosis Secondary to Proton-Pump Inhibitor Use.
    Digestion. 2018;97:195-204.
    PubMed     Text format     Abstract available


    October 2017
  16. HORIUCHI Y, Fujisaki J, Ishizuka N, Omae M, et al
    Study on Clinical Factors Involved in Helicobacter pylori-Uninfected, Undifferentiated-Type Early Gastric Cancer.
    Digestion. 2017;96:213-219.
    PubMed     Text format     Abstract available


    August 2017
  17. CHINDA D, Shimoyama T, Iino C, Matsuzaka M, et al
    Decrease of Estradiol and Several Lifestyle Factors, but Not Helicobacter pylori Infection, Are Significant Risks for Osteopenia in Japanese Females.
    Digestion. 2017;96:103-109.
    PubMed     Text format     Abstract available


    July 2017
  18. OHTSU T, Takagi A, Uemura N, Inoue K, et al
    The Ameliorating Effect of Lactobacillus gasseri OLL2716 on Functional Dyspepsia in Helicobacter pylori-Uninfected Individuals: A Randomized Controlled Study.
    Digestion. 2017;96:92-102.
    PubMed     Text format     Abstract available


    June 2017
  19. YAMASHITA H, Kanamori A, Kano C, Hashimura H, et al
    The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
    Digestion. 2017;96:52-59.
    PubMed     Text format     Abstract available


  20. FUNAKI Y, Kaneko H, Kawamura Y, Yoshimine T, et al
    Impact of Comorbid Irritable Bowel Syndrome on Treatment Outcome in Non-Erosive Reflux Disease on Long-Term Proton Pump Inhibitor in Japan.
    Digestion. 2017;96:39-45.
    PubMed     Text format     Abstract available


  21. KOTACHI T, Ito M, Yoshihara M, Boda T, et al
    Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.
    Digestion. 2017;95:314-318.
    PubMed     Text format     Abstract available


  22. YAMAGUCHI D, Sakata Y, Yoshida H, Furukawa NE, et al
    Effectiveness of Endoscopic Hemostasis with Soft Coagulation for Non-Variceal Upper Gastrointestinal Bleeding over a 12-Year Period.
    Digestion. 2017;95:319-326.
    PubMed     Text format     Abstract available


    May 2017
  23. SUGIMOTO M, Sahara S, Ichikawa H, Sakao Y, et al
    Natural Course of Helicobacter pylori Infection in Japanese Hemodialysis Patients.
    Digestion. 2017;95:302-309.
    PubMed     Text format     Abstract available


  24. OKUYAMA M, Nakahara K, Iwakura N, Hasegawa T, et al
    Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Digestion. 2017;95:281-287.
    PubMed     Text format     Abstract available


    March 2017
  25. KISHIKAWA H, Kimura K, Ito A, Arahata K, et al
    Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.
    Digestion. 2017;95:229-236.
    PubMed     Text format     Abstract available


  26. KASAMATSU S, Matsumura T, Ohta Y, Hamanaka S, et al
    The Effect of Ineffective Esophageal Motility on Gastroesophageal Reflux Disease.
    Digestion. 2017;95:221-228.
    PubMed     Text format     Abstract available


  27. MAJIMA A, Handa O, Naito Y, Dohi O, et al
    Early-Stage Gastric Cancer Can Be Found in Improved Atrophic Mucosa over Time from Successful Helicobacter pylori Eradication.
    Digestion. 2017;95:194-200.
    PubMed     Text format     Abstract available


    February 2017
  28. HOSHINO S, Kawami N, Takenouchi N, Umezawa M, et al
    Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis.
    Digestion. 2017;95:156-161.
    PubMed     Text format     Abstract available


  29. KAWAMI N, Takenouchi N, Umezawa M, Hoshino S, et al
    Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection.
    Digestion. 2017;95:140-145.
    PubMed     Text format     Abstract available


    January 2017
  30. OVERBY A, Murayama SY, Michimae H, Suzuki H, et al
    Prevalence of Gastric Non-Helicobacter pylori-Helicobacters in Japanese Patients with Gastric Disease.
    Digestion. 2017;95:61-66.
    PubMed     Text format     Abstract available


    December 2016
  31. TSUJIMAE M, Yamashita H, Hashimura H, Kano C, et al
    A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
    Digestion. 2016;94:240-246.
    PubMed     Text format     Abstract available


    June 2016
  32. MIURA K, Okada H, Kouno Y, Kanzaki H, et al
    Actual Status of Involvement of Helicobacter pylori Infection That Developed Gastric Cancer from Group A of ABC (D) Stratification - Study of Early Gastric Cancer Cases That Underwent Endoscopic Submucosal Dissection.
    Digestion. 2016;94:17-23.
    PubMed     Text format     Abstract available


  33. O'MORAIN C, Smith S
    Helicobacter pylori Treatment Failure: The Rationale for Alternative Antibiotics.
    Digestion. 2016;93:309-310.
    PubMed     Text format    


    May 2016
  34. OVERBY A, Yamagata Murayama S, Matsui H, Nakamura M, et al
    In the Aftermath of Helicobacter pylori: Other Helicobacters Rising Up to Become the Next Gastric Epidemic.
    Digestion. 2016;93:260-265.
    PubMed     Text format     Abstract available


    February 2016
  35. NIV Y
    Doxycycline in Eradication Therapy of Helicobacter pylori - A Systematic Review and Meta-Analysis.
    Digestion. 2016;93:167-173.
    PubMed     Text format     Abstract available


    January 2016
  36. YAMAGUCHI Y, Nagata Y, Hiratsuka R, Kawase Y, et al
    Gastric Cancer Screening by Combined Assay for Serum Anti-Helicobacter pylori IgG Antibody and Serum Pepsinogen Levels - The ABC Method.
    Digestion. 2016;93:13-18.
    PubMed     Text format     Abstract available


  37. SUGIMOTO M, Uotani T, Ichikawa H, Andoh A, et al
    Gastroesophageal Reflux Disease in Time Covering Eradication for All Patients Infected with Helicobacter pylori in Japan.
    Digestion. 2016;93:24-31.
    PubMed     Text format     Abstract available


  38. KAWAI T, Moriyasu F, Tsuchida A
    Key Issues Associated with Helicobacter pylori Eradication.
    Digestion. 2016;93:19-23.
    PubMed     Text format     Abstract available


  39. TAKESHITA E, Sakata Y, Hara M, Akutagawa K, et al
    Higher Frequency of Reflux Symptoms and Acid-Related Dyspepsia in Women than Men Regardless of Endoscopic Esophagitis: Analysis of 3,505 Japanese Subjects Undergoing Medical Health Checkups.
    Digestion. 2016;93:266-71.
    PubMed     Text format     Abstract available


    December 2015
  40. FURUTA K, Adachi K, Aimi M, Shimura S, et al
    Effect of Timing of Proton Pump Inhibitor Administration on Acid Suppression.
    Digestion. 2015;93:107-116.
    PubMed     Text format     Abstract available


    September 2015
  41. GLOCKER EO
    The Need for Resistance Surveillance and Antimicrobial Susceptibility Testing of Helicobacter pylori.
    Digestion. 2015;92:173-174.
    PubMed     Text format    


    July 2015
  42. NAVARRO-JARABO JM, Fernandez-Sanchez F, Fernandez-Moreno N, Hervas-Molina AJ, et al
    Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain.
    Digestion. 2015;92:78-82.
    PubMed     Text format     Abstract available


  43. GUNGOR G, Baglicakoglu M, Kayacetin E, Biyik M, et al
    Current Status of Five Different Regimens for Empiric First-Line Helicobacter pylori Eradication in Turkey.
    Digestion. 2015;92:55-59.
    PubMed     Text format     Abstract available


    January 2015
  44. KAWAMI N, Iwakiri K, Sano H, Tanaka Y, et al
    Effects of aging and acid reflux on esophageal motility.
    Digestion. 2015;91:181-6.
    PubMed     Text format     Abstract available


  45. RANTANEN TK, Sihvo EI, Rasanen JV, Hynninen M, et al
    Esophageal Ulcer as a Cause of Death: A Population-Based Study. Mortality of Esophageal Ulcer Disease.
    Digestion. 2015;91:272-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Peptic Ulcer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: